Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI

[1]  C. Canivet,et al.  Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events , 2022, Journal of Hepatology.

[2]  S. Grünert,et al.  The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI , 2021, Genes.

[3]  Aashish N. Adhikari,et al.  The Use of Whole Genome and Exome Sequencing for Newborn Screening: Challenges and Opportunities for Population Health , 2021, Frontiers in Pediatrics.

[4]  B. Geramizadeh,et al.  Novel mutations in the PHKB gene in an iranian girl with severe liver involvement and glycogen storage disease type IX: a case report and review of literature , 2021, BMC Pediatrics.

[5]  Min Liu,et al.  Liver Transplantation for Glycogen Storage Disease Type IV , 2021, Frontiers in Pediatrics.

[6]  F. de Boer,et al.  The potential of dietary treatment in patients with glycogen storage disease type IV , 2020, Journal of inherited metabolic disease.

[7]  S. Karimzadeh,et al.  Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature , 2020, Orphanet Journal of Rare Diseases.

[8]  P. Kishnani,et al.  Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX. , 2020, Molecular genetics and metabolism.

[9]  Jie Liu,et al.  Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review , 2020, Journal of pediatric endocrinology & metabolism : JPEM.

[10]  K. Hussain,et al.  Fanconi–Bickel Syndrome: A Review of the Mechanisms That Lead to Dysglycaemia , 2020, International journal of molecular sciences.

[11]  T. Battelino,et al.  A patient with glycogen storage disease type 0 and a novel sequence variant in GYS2: a case report and literature review , 2020, The Journal of international medical research.

[12]  H. Cheema,et al.  Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene , 2020, Journal of pediatric endocrinology & metabolism : JPEM.

[13]  J. Książyk,et al.  Over 20-Year Follow-up of Patients with Hepatic Glycogen Storage Diseases: Single-Center Experience , 2020, Diagnostics.

[14]  Rachel M. Brown,et al.  An uncommon cause of early infantile liver disease and raised chitotriosidase , 2020, JIMD Reports.

[15]  Kwang Yeon Kim,et al.  Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel. , 2020, European journal of medical genetics.

[16]  T. Strokova,et al.  Hepatic glycogen synthase (GYS2) deficiency: seven novel patients and seven novel variants , 2020, JIMD reports.

[17]  D. A. Weinstein,et al.  Glycogen Storage Disease Type VI , 2011, Definitions.

[18]  B. Maranda,et al.  Nocturnal enteral nutrition is therapeutic for growth failure in Fanconi‐Bickel syndrome , 2019, Journal of inherited metabolic disease.

[19]  M. Inbar‐Feigenberg,et al.  Use of waxy maize heat modified starch in the treatment of children between 2 and 5 years with glycogen storage disease type I: A retrospective study , 2019, Molecular genetics and metabolism reports.

[20]  A. Kozma,et al.  PERSISTENT ASYMPTOMATIC SEVERE HYPOGLYCAEMIA DUE TO TYPE 0A GLYCOGENOSIS - GENERAL AND ORO-DENTAL ASPECTS. , 2019, Acta endocrinologica.

[21]  D. A. Weinstein,et al.  Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies. , 2019, Advances in nutrition.

[22]  Xinhua Xiao,et al.  A novel PHKA2 mutation in a Chinese child with glycogen storage disease type IXa: a case report and literature review , 2019, BMC Medical Genetics.

[23]  Rachel H Horton,et al.  Recent developments in genetic/genomic medicine , 2019, Clinical science.

[24]  W. Chung,et al.  Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) , 2019 .

[25]  R. Lu,et al.  Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV. , 2019, JIMD reports.

[26]  A. Novelli,et al.  Persistent Hypoglycemia in Children: Targeted Gene Panel Improves the Diagnosis of Hypoglycemia Due to Inborn Errors of Metabolism , 2018, The Journal of pediatrics.

[27]  M. Tarnopolsky.  Myopathies Related to Glycogen Metabolism Disorders , 2018, Neurotherapeutics.

[28]  R. Płoski,et al.  Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities , 2017, Archives of medical science : AMS.

[29]  A. Perez-Atayde,et al.  Hepatocellular Carcinoma in Fanconi-Bickel Syndrome , 2018, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[30]  Z. Aycan,et al.  The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[31]  M. Skopkova,et al.  Congenital hyperinsulinism and glycogenosis-like phenotype due to a novel HNF4A mutation. , 2017, Diabetes research and clinical practice.

[32]  P. Lapunzina,et al.  A new variant in PHKA2 is associated with glycogen storage disease type IXa , 2017, Molecular genetics and metabolism reports.

[33]  B. Afroze,et al.  Fanconi–Bickel Syndrome: Two Pakistani Patients Presenting with Hypophosphatemic Rickets , 2016, Journal of Pediatric Genetics.

[34]  D. A. Weinstein,et al.  Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I. , 2015, JIMD reports.

[35]  Irene J. Hoogeveen,et al.  Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease. , 2015, JIMD reports.

[36]  D. A. Weinstein,et al.  Glycogen storage diseases: Diagnosis, treatment and outcome , 2016 .

[37]  Nir Giladi,et al.  Frequent misdiagnosis of adult polyglucosan body disease , 2015, Journal of Neurology.

[38]  M. Hochuli,et al.  Hepatic glycogen storage disorders: what have we learned in recent years? , 2015, Current opinion in clinical nutrition and metabolic care.

[39]  T. Derks,et al.  Evaluation of glycogen storage disease as a cause of ketotic hypoglycemia in children , 2015, Journal of Inherited Metabolic Disease.

[40]  A. Schulze,et al.  The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada. , 2014, Molecular genetics and metabolism.

[41]  D. A. Weinstein,et al.  Aggressive therapy improves cirrhosis in glycogen storage disease type IX. , 2013, Molecular genetics and metabolism.

[42]  S. Attri,et al.  An Indian girl with Fanconi-Bickel syndrome without SLC2A2 gene mutation , 2013, Journal of Pediatric Genetics.

[43]  F. Schütz,et al.  Hepatic glucose sensing is required to preserve β cell glucose competence. , 2013, The Journal of clinical investigation.

[44]  A. El-Hattab,et al.  Glycogen Storage Disease Type IV , 2013 .

[45]  C. Stanley,et al.  Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. , 2012, The Journal of clinical endocrinology and metabolism.

[46]  D. Bali,et al.  Glycogen storage disease type IX: novel PHKA2 missense mutation and cirrhosis. , 2012, Journal of pediatric gastroenterology and nutrition.

[47]  M. Al-Haggar.  Fanconi-Bickel syndrome as an example of marked allelic heterogeneity. , 2012, World journal of nephrology.

[48]  S. Grünert,et al.  Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype. , 2012, Molecular genetics and metabolism.

[49]  A. Depaoli-Roach,et al.  Glycogen and its metabolism: some new developments and old themes. , 2012, The Biochemical journal.

[50]  K. Hussain,et al.  Recurrent spontaneous hypoglycaemia causes loss of neurogenic and neuroglycopaenic signs in infants with congenital hyperinsulinism , 2011, Clinical endocrinology.

[51]  G. Tisone,et al.  Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. , 2011, Transplantation proceedings.

[52]  T. Fok,et al.  Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China. , 2011, Molecular genetics and metabolism.

[53]  Y. Kohno,et al.  Case of glycogen storage disease type VI (phosphorylase deficiency) complicated by focal nodular hyperplasia , 2009, Pediatrics International.

[54]  M. Côrrea-Giannella,et al.  A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0 , 2010, BMC Medical Genetics.

[55]  C. Ackerley,et al.  Identification of a novel mutation in GYS1 (muscle-specific glycogen synthase) resulting in sudden cardiac death, that is diagnosable from skin fibroblasts. , 2009, Molecular genetics and metabolism.

[56]  S. Salani,et al.  Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene , 2009, Journal of Inherited Metabolic Disease.

[57]  H. Ozen.  Glycogen storage diseases: new perspectives. , 2007, World journal of gastroenterology.

[58]  M. Orho-Melander,et al.  The Variable Clinical Phenotype of Liver Glycogen Synthase Deficiency , 2007, Journal of pediatric endocrinology & metabolism : JPEM.

[59]  D. A. Weinstein,et al.  Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia. , 2006, Molecular genetics and metabolism.

[60]  R. Gitzelmann,et al.  Liver glycogen synthase deficiency: A rarely diagnosed entity , 1996, European Journal of Pediatrics.

[61]  E. Sokal,et al.  Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis , 1992, European Journal of Pediatrics.

[62]  P. Willems,et al.  The natural history of liver glycogenosis due to phosphorylase kinase deficiency: A longitudinal study of 41 patients , 2005, European Journal of Pediatrics.

[63]  G. Visser,et al.  Characteristic growth pattern in male X-linked phosphorylase-b kinase deficiency (GSD IX) , 2003, Journal of Inherited Metabolic Disease.

[64]  R. Waldherr,et al.  Fanconi-Bickel syndrome , 1987, Pediatric Nephrology.

[65]  B. Burwinkel,et al.  Severe Phenotype of Phosphorylase Kinase-Deficient Liver Glycogenosis with Mutations in the PHKG2 Gene , 2003, Pediatric Research.

[66]  E. Ozer,et al.  No mutation in the SLC2A2 (GLUT2) gene in a Turkish infant with Fanconi-Bickel syndrome , 2003, Pediatric Nephrology.

[67]  M. Orho-Melander,et al.  Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations. , 2002, The Journal of pediatrics.

[68]  R. Parvari,et al.  The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies. , 2002, Current molecular medicine.

[69]  U. Ertan,et al.  Special feature: pathological case of the month. Glycogen storage disease with renal tubular dysfunction (type XI, Fanconi-Bickel syndrome). , 2000, Archives of Pediatrics & Adolescent Medicine.

[70]  R. Vink,et al.  Hepatocellular carcinoma in glycogen storage disease type IV , 2000, Archives of disease in childhood.

[71]  R. Santer,et al.  Fanconi-Bickel syndrome – the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature , 1998, European Journal of Pediatrics.

[72]  L. Groop,et al.  Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. , 1998, The Journal of clinical investigation.

[73]  B. Burwinkel,et al.  Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. , 1998, American journal of human genetics.

[74]  B. Burwinkel,et al.  Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene , 1998, Human Genetics.

[75]  B. Burwinkel,et al.  Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). , 1997, Human molecular genetics.

[76]  E. Vasiliauskas,et al.  Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[77]  B. Portmann,et al.  Glycogenosis type IV: liver transplant at 12 years. , 1994, Archives of Disease in Childhood.

[78]  R. Berger,et al.  Localization of a new type of X-linked liver glycogenosis to the chromosomal region Xp22 containing the liver alpha-subunit of phosphorylase kinase (PHKA2). , 1994, Genomics.

[79]  T. Starzl,et al.  Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. , 1993, The New England journal of medicine.

[80]  H. Reichmann,et al.  A mild juvenile variant of type IV glycogenosis , 1992, Brain and Development.

[81]  H. Greene,et al.  Hypoglycemia in type IV glycogenosis: hepatic improvement in two patients with nutritional management. , 1988, The Journal of pediatrics.

[82]  J. Henzen.  Publisher's note , 1979, Brain Research.

[83]  V. Ionasescu,et al.  Glycogenosis. IV. A new cause of infantile hypotonia. , 1972, The Journal of pediatrics.